We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

26 hedge funds and large institutions have $28.6K invested in CERo Therapeutics Warrants in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $28K → $28.6K (+$626)

13% less funds holding

Funds holding: 30 → 26 (-4)

16.38% less ownership

Funds ownership: 18.51% → 2.13% (-16%)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$1.65K
2
Walleye Capital
Walleye Capital
New York
-$799
3
Walleye Trading
Walleye Trading
New York
-$193
4
Bank of America
Bank of America
North Carolina
-$3
5
RCM
Robinson Capital Management
Michigan
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$4.1K – – –
MI
2
MMCAP International
Cayman Islands
$3.11K – – –
SCM
3
Saba Capital Management
New York
$2.71K – – –
LA
4
Linden Advisors
New York
$2.3K – – –
PC
5
Periscope Capital
Ontario, Canada
$2.27K -$1.65K -151,534 -36%
BOCH
6
Blue Owl Capital Holdings
New York
$2.25K – – –
HCM
7
Highbridge Capital Management
New York
$2.25K – – –
CSD
8
Clear Street Derivatives
New York
$2.23K – – –
CS
9
Clear Street
New York
$1.21K – – –
CCM
10
Context Capital Management
California
$1.01K – – –
QGA
11
Q Global Advisors
Texas
$1K – – –
NAM
12
Nexpoint Asset Management
Texas
$903 – – –
WCMNY
13
Westchester Capital Management (New York)
New York
$622 – – –
Walleye Trading
14
Walleye Trading
New York
$584 -$193 -17,721 -20%
TCM
15
Tenor Capital Management
New York
$415 – – –
YCM
16
Yakira Capital Management
Connecticut
$415 – – –
WAM
17
Wolverine Asset Management
Illinois
$363 – – –
WA
18
Whitebox Advisors
Minnesota
$208 – – –
RCM
19
Rivernorth Capital Management
Florida
$207 – – –
SSA
20
Schonfeld Strategic Advisors
New York
$124 – – –
Calamos Advisors
21
Calamos Advisors
Illinois
$104 – – –
DCM
22
Dupont Capital Management
Delaware
$104 – – –
SRF
23
Silver Rock Financial
California
$101 – – –
AA
24
Ancora Advisors
Ohio
$21 – – –
Bank of America
25
Bank of America
North Carolina
$4 -$3 -300 -38%
1
2

CEROW Hedge Fund Activity: Q4 2024 in Review

26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2024, worth a combined $28.6K — up 2.2% from $28K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CEROW and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.

The largest seller was Periscope Capital, cutting an estimated $1.65K.

  • 26 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2024, down from 30 in Q3 2024.
  • Funds reported $28.6K of CERo Therapeutics Warrants stock for Q4 2024, up 2.2% quarter-over-quarter.
  • 0 funds opened new CERo Therapeutics Warrants positions in Q4 2024 and 4 closed out, a net change of -4 holders.
  • The largest CERo Therapeutics Warrants seller in Q4 2024 was Periscope Capital, an estimated $1.65K sold.

Based on aggregated 13F filings for Q4 2024.